Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsShares Issued
Ratios

Axsome Therapeutics (AXSM) Long-Term Debt Issuances (2023 - 2025)

Historic Long-Term Debt Issuances for Axsome Therapeutics (AXSM) over the last 2 years, with Q3 2025 value amounting to $70.0 million.

  • Axsome Therapeutics' Long-Term Debt Issuances changed N/A to $70.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $100.0 million, marking a year-over-year change of. This contributed to the annual value of $85.0 million for FY2023, which is 8888.89% up from last year.
  • Axsome Therapeutics' Long-Term Debt Issuances amounted to $70.0 million in Q3 2025.
  • In the past 5 years, Axsome Therapeutics' Long-Term Debt Issuances registered a high of $70.0 million during Q3 2025, and its lowest value of $30.0 million during Q2 2023.